Ex Vivo Major Histocompatibility Complex I Knockdown Prolongs Rejection-free Allograft Survival

Background:. Widespread application of vascularized composite allotransplantation (VCA) is currently limited by the required lifelong systemic immunosuppression and its associated morbidity and mortality. This study evaluated the efficacy of ex vivo (after procurement but before transplantation) eng...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jessica B. Chang, MD, William J. Rifkin, BA, Marc A. Soares, MD, April Duckworth, MD, Nakul Rao, MD, Yee Cheng Low, MD, Jonathan P. Massie, MD, Piul S. Rabbani, PhD, Pierre B. Saadeh, MD, Daniel J. Ceradini, MD
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wolters Kluwer 2018-06-01
Series:	Plastic and Reconstructive Surgery, Global Open
Acceso en liña:	http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000001825
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!